PUBLISHER: Verified Market Research | PRODUCT CODE: 1731734
PUBLISHER: Verified Market Research | PRODUCT CODE: 1731734
Advances in neurotechnology and the rising prevalence of neurological illnesses are driving growth in the market for brain monitoring devices. Wearable EEG gadgets and real-time brain activity monitoring are revolutionizing medical diagnoses and research. This is likely to enable the market size surpass USD 7.36 Billion valued in 2024 to reach a valuation of around USD 11.05 Billion by 2032.
Rising mental health awareness, as well as need for individualized treatment solutions, are driving market growth. Key companies are concentrating on developing non-invasive and user-friendly devices to improve patient experience and data accuracy, which will drive market growth in both the clinical and consumer sectors. The rising demand for Brain Monitoring Devices is enabling the market grow at a CAGR of 5.74% from 2026 to 2032.
Brain Monitoring Devices Market: Definition/ Overview
Brain monitoring devices use electroencephalography (EEG), functional magnetic resonance imaging (fMRI), or other technologies to track neurological health and cognitive function. They are used to diagnose neurological illnesses, monitor brain activity during surgical procedures and evaluate cognitive function. These technologies aid in individualized treatment regimens and rehabilitation. In the future, brain monitoring gadgets are projected to improve with more precise, non-invasive ways. They might work with AI to perform real-time analysis and improve mental wellness and cognitive function.
The rising prevalence of neurological illnesses is projected to drive the market for brain monitoring devices. As the prevalence of disorders such as epilepsy, stroke and neurodegenerative diseases increases, there is a greater need for sophisticated diagnostic and monitoring tools. These technologies help with accurate diagnosis, treatment planning and monitoring of brain health. The increasing awareness of neurological diseases, combined with technological improvements, drives the usage of brain monitoring devices, propelling market growth.
The expensive cost of brain monitoring equipment may limit market growth. Expensive gadgets may hinder accessibility and acceptance, especially in developing countries or in smaller healthcare facilities. High costs might also limit funding for sophisticated technologies in medical contexts.
However, continued developments and technological innovations are expected to result in cost savings over time. As the industry expands and economies of scale are reached, prices may fall, thereby reducing some of these hurdles and driving wider use.
The growing demand for diagnosing and monitoring neurological diseases will drive expansion in the Electroencephalography (EEG) equipment market. EEG devices are critical for evaluating brain activity, diagnosing epilepsy, sleep problems and other neurological conditions.
As the prevalence of such illnesses increases, so does the demand for accurate and trustworthy diagnostic instruments such as EEG machines. Furthermore, advances in EEG technology and increasing awareness of neurological health are projected to drive adoption and growth in this category.
Providing more comprehensive patient care will drive growth in the hospital segment. Hospitals are strengthening their capacities to deliver comprehensive and integrated care, which includes modern diagnostics and continuous patient monitoring. This trend includes the use of sophisticated brain monitoring equipment to increase diagnostic accuracy and treatment efficacy in neurological diseases.
As hospitals improve their services to match better patient care standards, the demand for advanced brain monitoring technologies, such as EEG and other diagnostic instruments, is projected to rise, accelerating the segment's growth.
The market for brain monitoring devices in North America will be driven by advancements in healthcare infrastructure. The region's established healthcare infrastructure and continued investments in cutting-edge medical technology improve diagnostic and treatment capacities.
Advanced infrastructure promotes the use of advanced brain monitoring devices, allowing for early and accurate diagnostics of neurological diseases. As hospitals and medical facilities incorporate these technologies into their procedures, demand for brain monitoring devices is likely to surge, accelerating market growth in North America.
The rising incidence of neurological disorders will drive the Asia-Pacific brain monitoring device market. The rising prevalence of disorders like epilepsy, stroke and neurodegenerative diseases drives demand for better diagnostic technologies.
As the region's healthcare spending increase and access to medical technologies improves, the necessity for effective brain monitoring solutions grows. This tendency, together with growing healthcare infrastructure and awareness, is likely to significantly enhance the market for brain monitoring devices in Asia-Pacific.
The Brain Monitoring Devices Market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions and political support. The organizations are focusing on innovating their product line to serve the vast population in diverse regions.
Some of the prominent players operating in the Brain Monitoring Devices Market include:
Natus Medical Incorporated, Medtronic plc, Koninklijke Philips N.V., GE Healthcare, Siemens Healthineers, Compumedics Limited, BrainScope Company, Inc., NeuroWave Systems, Inc., Nihon Kohden Corporation, Cadwell Industries, Inc., Elekta AB, Advanced Brain Monitoring, CAS Medical Systems, Inc., NCC Medical Co., Ltd., and Neurosoft.
In December 2023, Nihon Kohden launched the One View feature for its Neuromaster G1 intraoperative neuromonitoring (IONM) system. The IONM program incorporates the patient's anesthetic, vital indicators (e.g., heart rate, SpO2, temperature) and neurological data.
In October 2022, Medtronic is taking bold new measures to change that by opening the Medtronic Neurovascular Co-Lab. An innovation method and venue for new ideas in stroke treatment.
BY APPLICATION (USD MILLION)
BY APPLICATION (K TONS)
OUTLOOK
CONSTRUCTION INDUSTRY
RUBBER
DIENE MONOMER, SUCH AS OTHER SYNTHETIC RUBBERS
(TPV)
NEW OPPORTUNITIES FOR EPDM MANUFACTURERS
(EPDM) MARKET